Texas has been deemed inefficient when it comes to energy. Photo courtesy of Thomas Miller/Breitling Energy

For a state that's home to the "Energy Capital of the World," Texas falls flat when it comes to energy efficiency. WalletHub, a personal finance site, ranked the most and least energy-efficient states, and Texas was named No. 42 of the 48 states evaluated.

The states were scored on home and auto efficiency out of an available 100 points. Home efficiency was calculated based on the ratio of total residential energy consumption to annual degree days, the days of the year in each region that require buildings to engage heating or cooling. Auto efficiency was established by factoring in the annual miles driven per year, gallons of gasoline consumed, and population. At the top of the national ranking were New York, Vermont, Utah, Rhode Island, and Massachusetts.

Texas, with its hot climate and underdeveloped public transportation systems, scored only 33.34 total points on the report. The state ranked No. 35 on home energy efficiency and No. 42 for auto energy efficiency. Texans drive over 271 billion miles annually and use over 19 billion gallons of gas, the second worst and worst rankings, respectively, among the states considered for this study.

The Environmental Protection Agency's research tells a different story of Texas' sustainability. The EPA's Green Power Partnership named its 2018 top local governments, and Texas cities claimed three spots in the top five. Houston was ranked No. 1, followed by Dallas at No. 2 and Austin at No. 5. This ranking is based on the annual green power usage — Houstonians use almost 1.1 million kilowatt hours of wind and solar energies annually.

According to the WalletHub report, each American household spends at least $2,000 annually on utilities and another $1,968 on gasoline and oil, which is up $59 from last year. New technologies and energy-efficient measures can reduce household utility costs by up to 25 percent, and a fuel-efficient car could save drivers over $700 annually, says WalletHub. The report's experts advised in properly weatherproofing homes; smart technology, such as thermostats; solar panels; and more.

---

This story originally appeared on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.